5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma.
Mark A ApplebaumErin K BarrJason KarpusDiana C West-SzymanskiMeritxell OlivaElizabeth A SokolSheng ZhangAlexandre ChlenskiHelen R SalwenEmma WilkinsonMarija DobraticRobert L GrossmanLucy A GodleyBarbara E StrangerChuan HeSusan L CohnPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
cfDNA 5-hmC profiles in children with neuroblastoma correlate with metastatic burden and warrants development as a biomarker of treatment response and outcome.